Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Semi-automatic synthesis and biodistribution of N-(2- 18 F-fluoropropionyl)-bis(zinc (II)-dipicolylamine) ( 18 F-FP-DPAZn2) for AD model imaging.

BMC Medical Imaging 2017 April 22
BACKGROUND: Phosphatidylserine (PS)-targeting positron emission tomography (PET) imaging with labeled small-molecule tracer is a crucial non-invasive molecule imaging method of apoptosis. In this study, semi-automatic radiosynthesis and biodistribution of N-(2-18 F-fluoropropionyl)-bis(zinc(II)-dipicolylamine) (18 F-FP-DPAZn2), as a potential small-molecule tracer for PET imaging of cell death in Alzheimer's disease (AD) model, were performed.

METHODS: 18 F-FP-DPAZn2 was synthesized on the modified PET-MF-2V-IT-I synthesizer. Biodistribution was determined in normal mice and PET images of AD model were obtained on a micro PET-CT scanner.

RESULTS: With the modified synthesizer, the total decay-corrected radiochemical yield of 18 F-FP-DPAZn2 was 35 ± 6% (n = 5) from 18 F- within 105 ± 10 min. Biodistribution results showed that kidney has the highest uptake of 18 F-FP-DPAZn2. The uptake of radioactivity in brain kept at a relatively low level during the whole observed time. In vivo 18 F-FP-DPAZn2 PET images demonstrated more accumulation of radioactivity in the brain of AD model mice than that in the brain of normal mice.

CONCLUSIONS: The semi-automatic synthetic method provides a slightly higher radiochemical yield and shorter whole synthesis time of 18 F-FP-DPAZn2 than the manual operation method. This improved method can give enough radioactivity and high radiochemical purity of 18 F-FP-DPAZn2 for in vivo PET imaging. The results show that 18 F-FP-DPAZn2 seems to be a potential cell death tracer for AD imaging.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app